Treatment and Outcomes of Kidney Transplant Recipients with C4d Negative Antibody Mediated Rejection
Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Rejection After Change in Maintenance Immunosuppression Regimens in the First Year Post Kidney Transplant
Utility of Donor-Derived Cell Free DNA for Detecting ABMR in Patients With AT1R Antibodies
2021 American Transplant Congress